Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor

Potential New Therapeutic Agents for Diabetic Kidney Disease

(2010) Faruk Turgut et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine

(2010) Aaron B. Baker et al.   ATHEROSCLEROSIS

Glucose-induced endothelial heparanase secretion requires cortical and stress actin reorganization

(2010) Fang Wang et al.   CARDIOVASCULAR RESEARCH

AGEs increased migration and inflammatory responses of adventitial fibroblasts via RAGE, MAPK and NF-κB pathways

(2009) YaYang Liu et al.   ATHEROSCLEROSIS

Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK

(2009) Takahisa Tanikawa et al.   JOURNAL OF VASCULAR RESEARCH

Heparanase Alters Arterial Structure, Mechanics, and Repair Following Endovascular Stenting in Mice

(2008) Aaron B. Baker et al.   CIRCULATION RESEARCH

THE AGE/RAGE AXIS IN DIABETES-ACCELERATED ATHEROSCLEROSIS

(2008) Karin Jandeleit-Dahm et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Role of AGEs in Diabetic Nephropathy

(2008) Kei Fukami et al.   CURRENT PHARMACEUTICAL DESIGN

Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication

(2008) Sho-ichi Yamagishi et al.   CURRENT PHARMACEUTICAL DESIGN

Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy: Implications for the therapeutic use of low-molecular weight heparin

(2008) E. J. Lewis et al.   DIABETES CARE